Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part

Affiliation auteurs!!!! Error affiliation !!!!
TitreRandomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part
Type de publicationJournal Article
Year of Publication2015
AuteursHebbar M., Heurgue-Berlot A., Boige V., Le Malicot K., Bernard-Chabert B., Marcus C., Dharancy S., Sergent G., Perarnau J.M, Ehrhard F., Ollivier-Hourmand I., Vergniol J., Michel P., Edeline J., Rinaldi Y., Seitz J.F, Lepage C., De Baere T.
JournalEUROPEAN JOURNAL OF CANCER
Volume51
PaginationS434
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0959-8049
DOI10.1016/S0959-8049(16)31221-7